Information Provided By:
Fly News Breaks for August 13, 2019
GSK
Aug 13, 2019 | 06:51 EDT
JPMorgan analyst James Gordon reinstated coverage of GlaxoSmithKline with a Neutral rating and 1,700p price target. The analyst sees the stock near-term being Brexit and currency moves.
News For GSK From the Last 2 Days
There are no results for your query GSK